NAVIGATION
 
> Home
> OPPI Vision
> OPPI Mission
> Office Bearers 
> Committees
> News and Events
  OPPI 43rd AGM
> Keynote address by Shri Ashok Kumar, Secretary, DoP
> Address by Mr. Ranga Iyer, President, OPPI
> Address Mr. Ranjit Shahani, Incoming President, OPPI
> OPPI Position on IPR
> Pharma Spectrum - Monthly News At A Glance
> Pharma Spectrum 2009 - News at a glance
> Pharma Spectrum 2008 - Year at a glance
> OPPI Position on Biosimilars
> OPPI Position on Data Protection
> OPPI Anti - Counterfeiting Guidelines
> A Handy Guide for Road Safety
> A OPPI IPR Symposium Videos
> Patents
> Drug Policy & Pricing
> Regulatory
> Links
> India OTC Profile 2008
> Important Government Notifications
   
 

 

IFPMA Clinical
Trials Portal

IFPMA - Improving
Global Health


OPPI Code of
Pharmaceutical Marketing
Practices 2007


OPPI - YES Bank Report,
Pharmaceutical Industry:
Vision 2015


OPPI IPR
Symposium Proceedings

 




About Us Members Publications Contact Us
 
  OPPI PUBLICATIONS
 
 
43rd Annual Report – 2008-09
 
The Annual Report is a chronicle of various initiatives and multi-dimensional activities of the various OPPI Special Committees during the year 2008-09.

Price: (excluding Service Tax) 
Local – Indian Rupees: 500
International - U.S.$ 30

Download Free 42.2 Mb
Click for more details
Order Form

  

 

OPPI Code of Pharmaceutical Marketing Practices - 2007

 

 

Download Free


  
 

OPPI & Ernst & Young Report 2009 - Taking Wings

Coming of age of the Indian pharmaceutical outsourcing industry.

 

 

Download Free
Click for more details

  
 

OPPI Guidelines on Cold Chain Pharmaceutical Products

 

 

Download Free
Click for more details

  

OPPI Code on Conduct of Clinical Trials

 

 

Download Free
Click for more details

  
 

OPPI - YES Bank Report, "Pharmaceutical Industry: Vision 2015"

 

 

Download Free
Click for more details

  
  OPPI – Guide to Road Safety

.

Price: (excluding Service Tax) 
Local – Indian Rupees: 20 + Courier Charges

Download Free (11.5 Mb)
Click for more details
Order Form

 

OPPI IPR Symposium Proceedings

.





Download Free (27.2 Mb)
   

OPPI IPR Symposium Videos

.



Click for more details
 

OPPI – Environment, Health & Safety Guide – 2002-03

This is the Third Edition of the Guide.

Price: (excluding Service Tax) 
Local – Indian Rupees: 850
International: U.S.$ 30

Click for more details
Order Form

Outsourcing Opportunities in Indian Pharmaceutical Industry

The Pharmaceutical Industry in India is increasingly being recognised as a reliable source of quality medicines at affordable prices and is emerging as a global powerhouse.

Price: (excluding Service Tax)
Local – Indian Rupees: 1075
International: U.S.$ 40

Click for more details
Order Form

  

OPPI Pharmaceutical Compendium – (November 2004)

As we enter the Knowledge Economy, speedy and efficient exchange of reliable information will be a prime requirement for the efficient management of our intellectual capital.

Price: (excluding Service Tax) 
Local – Indian Rupees: 1,600
International: U.S.$ 80

Click for more details
Order Form

  

Corporate Social Responsibility of Pharmaceutical Companies in India: Practices, Perspectives and Way Forward

OPPI in collaboration with S.P. Jain Institute of Management & Research (SPJIMR) has completed the above Research Project to study how the Pharmaceutical Industry in India, whose primary mission is to improve the quality of life of its customers through its products and services, can leverage this strength for sustainable business growth.

Price: (excluding Service Tax)
Local: Indian Rupees 1,000
International:  U.S.$  45

Download Free (10.5 Mb)
Click for more details
Order Form

  

OPPI Guidelines on Good Laboratory Practices (GLP)

This document contains Guidelines for test facilities which are part of a manufacturing organisation that conduct studies (tests) which are not “regulatory studies”.

Price: (excluding Service Tax) 
Local – Indian Rupees: 120
International: U.S.$ 10

Click for more details
Order Form

  

OPPI Anti-Counterfeiting Guidelines

Counterfeit medicines represent an unacceptable risk to patient safety whilst at the same time jeopardizing the original manufacturer’s image, reputation and, in extreme cases, their economic viability. It is therefore imperative that every manufacturer of prescription and OTC medicines has in place an effective operating procedure, to make counterfeiting difficult and, to facilitate detection and investigation.

Price: (excluding Service Tax)
Local: Indian Rupees 150
International:  U.S.$  10

Download Free
Click for more details
Order Form

  



            Copyright © 2008. Organisation of Pharmaceutical Producers of India. All Rights Reserved.  |   Disclaimer  |